August 9, 2017 (Investorideas.com Newswire) Viridian Capital Advisors, LLC reports on its weekly Viridian Activity in the Cannabis Industry for the week ending August 4, 2017.

Capital Raises

Mergers & Acquisitions

Summary of Year-to-Date Transactions

Capital Raises


Mergers & Acquisitions


Announcements for Week Ended August 4, 2017

Capital Raises

Biotech/Pharma
Arena Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

Vitality Biopharma Closes $1 Million Private Placement

Cultivation & Retail
TerrAscend Closes First Tranche of its Private Placement

ABcann and Cannabis Wheaton Announce Closing of C$15 Million Investment

Tokyo Smoke Closes on C$4 Million of Series B Funding

Hemp
Aurora and Hempco Agree on Terms for Strategic Investment

Infused Products & Extracts
Wildflower Announces Private Placement

Investments/M&A
Marijuana Company of America Announces a $5 Million Fixed Funding Commitment

Mergers & Acquisitions

Consumption Devices
Gilla Completes Acquisition of Leading Canadian Vape Company

Infused Products & Extracts
Cannabis Sativa Acquires 51% of PrestoDoctor, a Premier Medical Marijuana Telemedicine Platform

Investments/M&A
LGC Capital Cannabis Partnership Makes Second Payment under Agreements to Acquire 60% Interest in South Africa’s House of Hemp

New York State Department of Health Approves iAnthus’ Proposed Acquisition of Valley Agriceuticals

Miscellaneous Ancillary
American Green, Inc. Purchases Town of Nipton, California, with Plans to Develop Premier Cannabis Hospitality Destination

Anything Technologies Media Acquires Biotech Company Shield Global specializing in “Anti-microbial” Surface Products to Protect Against Harmful Viruses, Bacteria, Molds, and Fungi

Going-Public Transaction

Cultivation & Retail
DOJA Cannabis Company Announces Closing of Transaction and Initial Trading Date

Spin-Offs

Investments/M&A
NSAV Announces Record Date for Shareholder Dividend from Hemp Beer Spin Off

To Learn More About the Viridian Cannabis Deal Tracker, Contact:

Harrison Phillips
Viridian Capital Advisors, LLC
(212) 209-3086
hphillips@viridianca.com

Disclaimers

The information contained herein is for informational purposes and is not intended as a research report. It should not be construed as Viridian recommending investment in cannabis companies or as a solicitation to buy or sell any security or engage in a particular investment strategy. Investment in cannabis companies entails substantial risk. Before acting on any information, you should consider whether it is suitable for your particular circumstances and consult all available material, and, if necessary, seek professional advice.

Viridian Capital Advisors and its affiliates, as well as their respective partners, directors, shareholders, and employees, may have a position in the securities mentioned herein or may make purchases and/or sales from time to time. Viridian Capital Advisors, through broker-dealer services provided by Pickwick Capital Partners, LLC, (Member FINRA/SIPC), may act, or may have acted in the past, as a financial advisor to certain companies mentioned herein and may receive, or may have received, a remuneration for their services from those companies.

About the Viridian Cannabis Deal Tracker

The Viridian Cannabis Deal Tracker monitors capital raise, mergers & acquisition, joint venture, and licensing activity for both public and private companies in the legal cannabis industry across 12 key sectors, including Agriculture Technology, Biotech/Pharma, Consulting Services, Consumption Devices, Cultivation & Retail, Hemp, Investments/M&Amp;Amp;Amp;A (Holding Companies), Infused Products & Extracts, Miscellaneous Ancillary, Physical Security, Real Estate, and Software/Media.

Integrating more than 3 years of data collection, segmentation, and analysis, the Viridian Cannabis Deal Tracker supports decision-making by providing sector-specific actionable intelligence and trend analysis in regard to issuers, investors, acquirers, valuations, deal structures, and deal terms.

The above information whether in part or in its entirety neither constitutes an offer nor makes any recommendation to buy or sell any securities.

About Viridian Capital Advisors, LLC

Viridian Capital Advisors (www.viridianca.com) is a financial and strategic advisory firm dedicated to the cannabis market. We are a data- and market intelligence-driven firm that provides investment banking, M&Amp;Amp;Amp;A, corporate development, and investor relations services to emerging growth companies and qualified investors in the cannabis sector. Our banking practice, through broker-dealer Pickwick Capital Partners, LLC (Member FINRA/SIPC), provides capital and M&Amp;Amp;Amp;A to fund the growth of our clients, while our advisory practice helps to position and build their businesses. Our team’s decades of high level operating and transactional experience on Wall Street in a variety of emerging sectors, allows Viridian to provide comprehensive strategic and financial solutions that assist cannabis enterprises in realizing their full potential.

Marijuana remains illegal under federal law. The Federal Government does not recognize marijuana to have any medicinal values. Marijuana cultivation, possession, consumption, sales, and distribution are illegal under federal laws and also certain state laws. Please note that there are differences in marijuana laws from one state, county, or city to another.

Marijuana / Hemp Stocks

More Info:

Investorideas.com Newswire

This news is published on the Investorideas.com Newswire – a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 – all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Questrade Democratic Pricing - 1 cent per share, $4.95 min / $9.95 max

Source: New feed